Jefferies Financial Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.2M Buy
103,833
+99,544
+2,321% +$20.6M 0.13% 150
2026
Q1
$963K Sell
4,289
-10,030
-70% -$2.5M 0.01% 940
2025
Q4
$3.45M Sell
14,319
-7,516
-34% -$1.92M 0.02% 593
2025
Q3
$5.98M Buy
21,835
+17,317
+383% +$4.73M 0.03% 320
2025
Q2
$1.17M Sell
4,518
-10,782
-70% -$2.57M 0.01% 682
2025
Q1
$3.42M Buy
15,300
+7,994
+109% +$1.87M 0.03% 408
2024
Q4
$1.67M Sell
7,306
-6,271
-46% -$1.51M 0.01% 731
2024
Q3
$3.31M Sell
13,577
-147,336
-92% -$32.9M 0.02% 425
2024
Q2
$31.1M Buy
160,913
+146,613
+1,025% +$29.7M 0.33% 51
2024
Q1
$2.83M Buy
+14,300
New +$2.62M 0.03% 471
2023
Q4
– Sell
-10,211
Closed -$1.51M – 1946
2023
Q3
$1.51M Buy
+10,211
New +$1.85M 0.01% 699
2023
Q1
– Sell
-10,000
Closed -$2.08M – 1941
2022
Q4
$2.08M Buy
+10,000
New +$2.2M 0.01% 642

Other funds holding RMD

Jefferies Financial Group's RMD Position: Q2 2026 in Review

Jefferies Financial Group increased its ResMed (RMD) stake by 2,321% in Q2 2026, buying an estimated $20.6M and bringing the position to 103,833 shares worth $20.2M. The position accounts for 0.13% of the portfolio, ranked #150.

Jefferies Financial Group first reported a position in RMD in Q4 2022 and has held it in 12 quarters since. The position peaked at $31.1M in Q2 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Jefferies Financial Group held 103,833 shares of ResMed worth $20.2M as of Q2 2026.
  • Jefferies Financial Group bought 99,544 ResMed shares in Q2 2026, an estimated $20.6M.
  • ResMed made up 0.13% of Jefferies Financial Group's portfolio in Q2 2026, its #150 holding.
  • Jefferies Financial Group first reported a position in ResMed in Q4 2022 and has held it in 12 quarters since.
  • Jefferies Financial Group's ResMed position peaked at $31.1M in Q2 2024.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.